// October 05, 2016
// May 24, 2016
Pharmaceutical Manufacturing in LMICs: Where Things Go Wrong
The Root Causes of Substandard Medicines in Lower and Middle Income Countries (LMICs)
// April 14, 2016
Our Concerns Regarding Congressional Proposal to Discard Public Quality and Safety Standards for Biologics
It is well known that scientific developments in biologic drugs—therapies manufactured in living
// March 31, 2016
A Multi-Sectorial Approach to Ensuring Medical Product Quality & Supply Chain Integrity
By: Victor Pribluda, Manager, Promoting the Quality of Medicines–Latin Ame